Summary of findings 2. Laser compared to placebo/no treatment for patients with dentinal hypersensitivity tested via VAS with the value range from 0 to 10 (no pain to worst possible pain) in response to tactile stimuli.
Laser compared to placebo/no treatment for patients with dentinal hypersensitivity tested via VAS with the value range from 0 to 10 (no pain to worst possible pain) in response to tactile stimuli | |||||
Patient or population: patients with dentinal hypersensitivity Setting: dental clinic Intervention: laser Comparison: placebo/no treatment | |||||
Outcomes | Anticipated absolute effects* (95% CI) | Number of teeth (studies) | Certainty of the evidence (GRADE) | Comments | |
Risk with placebo/no treatment | Risk with laser | ||||
Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through tactile stimuli ‐ short term (0 to 24 hours) All types of laser | The mean changes in pain intensity ranged from 0.10 to 3.17 | MD 0.67 lower (1.31 lower to 0.03 lower) | 506 (8 RCTs) | ⊕⊕⊝⊝ LOWa,b | Lasers may reduce pain intensity in the short term when compared to placebo/no treatment. Pain reduction was observed in the lasers group in the short term with a mean VAS score difference of 0.65 suggesting minimal clinical significance. The effective laser in this category was diode |
Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through tactile stimuli ‐ medium term (24 hours to 2 months) All types of laser | The mean changes in pain intensity ranged from 0.30 to 3.60 | MD 1.73 lower (3.17 lower to 0.30 lower) | 591 (9 RCTs) | ⊕⊝⊝⊝ VERY LOWa,c | Lasers may reduce pain intensity in the medium term when compared to placebo/no treatment but the evidence is very uncertain. Pain reduction was observed in the lasers group in the medium term with a mean VAS score difference of 1.14 suggesting minimal clinical significance. The effective lasers in this category were GaAlAs and diode |
Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through tactile stimuli ‐ long term (more than 2 months) All types of laser | The mean changes in pain intensity ranged from 0.50 to 2.30 | MD 3.52 lower (10.37 lower to 3.33 higher) | 184 (2 RCTs) | ⊕⊝⊝⊝ VERY LOWd,e,f | There was insufficient evidence of a difference in pain intensity for all types of lasers in the long term |
Adverse events | No adverse event was noted in the experimental and control groups | 386 (5 RCTs) |
⊕⊕⊝⊝ LOWg | ‐ | |
Patient‐reported quality of life | Outcome not measured in any of the included studies | ||||
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; GaAIAs: gallium‐aluminum‐arsenide; MD: mean difference; RCT: randomized controlled trial; VAS: visual analogue scale | |||||
GRADE Working Group grades of evidence High certainty: we are very confident that the true effect lies close to that of the estimate of the effect Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect |
aDowngraded 1 level for risk of bias: studies with significant contribution to data analysis were rated as at unclear and high risk of bias for randomization and blinding of outcome assessors. bDowngraded 1 level for inconsistency: marked heterogeneity with I2 = 92% and some studies crossing the threshold. cDowngraded 2 levels for inconsistency: marked heterogeneity with I2 = 97% and some studies crossing the threshold. dDowngraded 1 level for risk of bias: the study with significant contribution to data analysis was rated as at unclear risk of bias for selection, detection, and attrition bias. eDowngraded 2 levels for inconsistency: marked heterogeneity with I2 = 99%. fDowngraded 1 level for imprecision: wide confidence interval crossing the threshold. gDowngraded 1 level each for risk of bias and imprecision.